Team-Based Care for Type 2 Diabetes
(iPATH Trial)

Recruiting in Palo Alto (17 mi)

+3 other locations

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Stanford University

No Placebo Group

Trial Summary

What is the purpose of this trial?Sixteen institutions will be selected from a HRSA uniform data system and have data collected for up to 3 years. Eight institutions will begin the iPATH practice transformation during year one, the other eight institutions will begin iPATH in year two. FQHC administrators, clinicians and staff will be enrolled to participate in the iPATH transformation in their clinic and will participate in qualitative interviews. Patient HbA1c data from the clinics will be collected for comparative data analysis during each year of the study.

Eligibility Criteria

The iPATH trial is for the two largest clinic sites within multi-clinic FQHCs located in or near Massachusetts, Ohio, California, and Puerto Rico. These clinics should be performing in the mid-range for diabetes control (3rd quartile) with adult patients having poorly controlled diabetes.

Inclusion Criteria

Organizations included will be the two largest clinic sites in multi-clinic FQHCs operating in or near Massachusetts, Ohio, California, Puerto Rico, performing in the 3rd quartile for percentage of patients with poorly controlled diabetes (A1c>9%)

Exclusion Criteria

Exclude FQHCs that have a patient population comprised of more than 80% children

Exclude FQHCs that have a patient population multiplied by the FQHC's diabetes prevalence in the lowest 10% of all the clinics

Exclude FQHCs that have fewer than 5,000 or more than 50,000 patients

Participant Groups

iPATH aims to improve type 2 diabetes care by refining a practice transformation approach at FQHCs. It involves identifying effective organizational processes pre- and post-pandemic, implementing technology-enabled strategies tailored to each clinic's needs, and evaluating these changes using a hybrid study design.

2Treatment groups

Experimental Treatment

Group I: Wave 2 ClinicsExperimental Treatment1 Intervention

Clinics will have data evaluated for up to 3 years. Wave 2 clinics will begin the iPATH practice transformation in Year 2.

Group II: Wave 1 ClinicsExperimental Treatment1 Intervention

Clinics will have data evaluated for up to 3 years. Wave 1 clinics will begin the iPATH practice transformation in Year 1.